Clinical Trial Update: Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating maintenance therapy with low-dose oral cyclophosphamide and methotrexate in hormone receptor-negative early breast cancer has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-12-11